Interleukin-1 (IL-1), 1 a major inflammatory cytokine, exerts its biological effects by activating the transcription of various responsive genes (1) . The transcription factors activated by IL-1 include NFB (Rel proteins), AP1, and ATF (2-4). The IL-1 receptor belongs to the IL-1R/TLR (Toll-like receptor) superfamily. Human TLRs have recently emerged as key components in the generation of immune and inflammatory responses because of their ability to recognize pathogen-associated molecules (5) . The signaling pathway downstream of mammalian IL-1R/TLR is evolutionally conserved with that initiated by the Drosophila Toll protein (5, 6) . Drosophila Toll controls dorsoventral axis formation in embryogenesis and has a role in the anti-fungal immune response in the adult fly (6) .
Upon IL-1 stimulation, the adaptor molecules MyD88 and Tollip are recruited to the IL-1 receptor complex, which then recruits the serine-threonine kinases IRAK4 and IRAK. IRAK is hyperphosphorylated, mediating the recruitment of TRAF6 to the receptor complex (7) (8) (9) (10) (11) (12) . IRAK-TRAF6 then leaves the receptor complex to interact with pre-associated TAK1, TAB1, and TAB2 on the membrane. TAK1 and TAB2 are phosphorylated on the membrane, which facilitates the formation and translocation of the TRAF6-TAK1-TAB1-TAB2 complex from the membrane to the cytosol. TAK1 is subsequently activated in the cytosol, leading to the activation of IB kinase (IKK). Activated IKK causes the activation of NFB through the phosphorylation and degradation of IBs, which sequester NFB prior to activation. Activation of TAK1 also results in the activation of mitogen-activated protein kinases and c-Jun NH 2 -terminal kinase.
Drosophila Toll is activated by the endogenous ligand Spaetzle, leading to the activation of Dif (Rel protein) through the degradation of Cactus, the Drosophila homologue of the mammalian IBs, which sequester Dif prior to activation. Toll signals through the adapter molecule Tube and the serinethreonine kinase Pelle (13) . Although no mammalian counterpart has been found for Tube, Pelle is highly homologous to IRAK4 and IRAK (7) (8) (9) (10) . Drosophila TRAF (dTRAF) has also been identified and shown to interact with Pelle (14) . Therefore, the Toll-Pelle-dTRAF-Cactus-Dif cascade is quite analogous to the mammalian IL-1R/TLR-IRAK4/IRAK-TRAF6-IB-NFB pathway (14) . However, the downstream signaling events from Pelle-dTRAF to Cactus are not clear. When Pelle was used as bait in a yeast two-hybrid screening, a novel Pelle-interacting protein called Pellino was identified (15) . Pellino was shown to only interact with the catalytically active Pelle but not with a kinase-dead Pelle mutant, suggesting that Pellino may play an important role in facilitating the function of Pelle. In this study, we report the identification of mammalian Pellino (termed Pellino 1) and its role in IL-1-mediated signaling.
EXPERIMENTAL PROCEDURES
Biological Reagents and Cell Culture-Recombinant human IL-1␤ was provided by the NCI, National Institutes of Health. Anti-IRAK4 was a gift from Dr. Holger Wesche (Tularik, South San Francisco, CA). Anti-TRAF6, anti-IRAK, and anti-IL-1R were from Santa Cruz Biotechnology. Rabbit anti-TAK1, anti-TAB1, and anti-TAB2 polyclonal antibodies were kindly provided by Dr. Kunihiro Matsumoto (16, 17) . Anti-FLAG (M2) was from Sigma. HEK293-TK/Zeo cells, I1A, and I3A (18) were maintained in Dulbecco's modified Eagle medium supplemented with 10% fetal calf serum, penicillin G (100 g/ml), and streptomycin (100 g/ml).
Recombinant Plasmids and Stable Transfection-pE-selectin-luc, an NFB-dependent E-selectin-luciferase (E-selectin-luc) reporter plasmid, was described by Schindler and Baichwal (19) . Dominant negative * This work was supported by National Institutes of Health Grant GM 600020 (to X. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Immunology, Lerner Research Inst., Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-445-8706; Fax: 216-444-9329; E-mail: Lix@ccf.org. 1 The abbreviations used are: IL-1, interleukin-1; IL-1R, IL-1 receptor; TLR, Toll-like receptor; NFB, nuclear factor B; IRAK, IL1R-associated kinase; TRAF, tumor necrosis factor receptor-associated factor; TAK, transforming growth factor ␤-activated kinase; TAB, TAK-1-binding protein; Pellino 1, mammalian Pellino; HEK293, human embryonic kidney 293. TAK1 (DNTAK1-K66W) was a kind gift from Dr. Kunihiro Matsumoto (Nagoya University, Nagoya, Japan). The vector pSUPER was obtained from Dr. Reuven Agami's group (Center for Biomedical Genetics, Leiden, The Netherlands). Pellino 1-pSUPER was constructed by cloning primers derived from Pellino 1 (47-66 bp) according to the methods described by Brummelkamp et al. (20) . For stable transfections, 2 ϫ 10 5 cells were seeded onto a 10-cm plate and cotransfected the following day by the calcium phosphate method with 10 g of each expression vector and 1 g of pBabePuro. After 48 h, the cells were selected with 1 g/ml puromycin until clones appeared.
Co-immunoprecipitation and Immunoblotting-6 ϫ 10 5 cells were seeded onto each 15-cm plate and transfected the following day by the calcium phosphate method with 15 g of FLAG-tagged Pellino 1. After 48 h, cells untreated or treated with 100 units/ml of IL-1 were lysed in a Triton-containing lysis buffer (0.5% Triton X-100, 20 mM HEPES, pH 7.4, 150 mM NaCl, 12.5 mM ␤-glycerophosphate, 1.5 mM MgCl 2 , 10 mM NaF, 2 mM dithiothreitol, 1 mM sodium orthovanadate, 2 mM EGTA, 20 M aprotinin, and 1 mM phenylmethylsulfonyl fluoride). Cell extracts were incubated with 1 g of antibody or preimmune serum (negative control) for 2 h, followed by a 2-h incubation with 20 l of protein A-Sepharose beads (pre-washed and resuspended in phosphate-buffered saline at a 1:1 ratio). After incubation, the beads were washed four times with lysis buffer, separated by SDS-PAGE, transferred to Immobilon-P membranes (Millipore), and analyzed by immunoblotting.
Reporter Assays-2 ϫ 10 5 cells were transfected by the same procedure as described above with 1 g of pE-selectin-luc, 1 g of pSV 2 -␤-gal, and 100 ng of each expression construct. After 48 h, the cells were split onto two 35-mm plates and stimulated with IL-1 the next day for 4 h before harvest. Luciferase and ␤-galactosidase activities were determined by using the luciferase assay system and chemiluminescent reagents from Promega (Madison, WI).
Gel Shift Assays-An NFB binding site (5Ј-GAGCAGAGGGAAAT-TCCGTAACTT-3Ј) from the IP-10 gene was used as a probe (21) . Complementary oligonucleotides, end-labeled with polynucleotide kinase (Roche Molecular Biochemicals) and ␥-32 P-labeled ATP, were annealed by slow cooling. Approximately 20,000 cpm of probe were used per assay (22) . Whole cell extracts were used for the assay. The binding reaction was carried out at 4°C for 20 min in a total volume of 20 l containing 20 mM Hepes buffer, pH 7.0, 10 mM KCl, 0.1% Nonidet P-40, 0.5 mM dithiothreitol, 0.25 mM phenylmethanesulfonyl fluoride, and 10% glycerol. 
IL-1 Induces the Interaction of Pellino 1 with IRAK4
and IRAK-Human Pellino 1 cDNA, cloned from a human dermal fibroblast cDNA library, encodes an open reading frame of 418 amino acid residues (accession number NP_065702, Fig. 1a ). To identify functionally important regions of Pellino 1, the mammalian Pellino 1 was aligned with those from other species (Fig. 1 ). There is a surprising degree of similarity between the human Pellino 1 sequence and the homologous protein from Caenorhabditis elegans, which share 44% amino acid identity and 53% similarity. The C-terminal portion of Pellino 1 contains two invariant Cys-Gly-His triplets, two invariant CysPro-X-Cys motifs (where X is a hydrophobic residue), and a conserved Cys-Pro-Val motif (Fig 1a) , reminiscent of the structure of the C3HC4 Ring finger subfamily of zinc finger domains (23) , which mediate diverse protein-protein interactions of tumor suppressors, protooncogenes, and signaling molecules such as TRAFs. Pellino 1 is ubiquitously expressed; it is expressed highly in peripheral blood leukocytes, moderately in placenta, lung, liver, kidney, spleen, thymus, skeletal muscle, and brain, and at a low level in small intestine, colon and heart (Fig. 1b) .
We examined whether mammalian Pellino 1 interacts with IRAK and IRAK4, which are the mammalian counterparts of Pelle (7, 9, 10, 24) . Because IRAK and IRAK4 are essential signaling components in the IL-1 pathway, the interaction of Pellino 1 with IRAK and IRAK4 was studied upon IL-1 stimulation. Cell extracts prepared from HEK293 cells transfected with FLAG-tagged Pellino 1, either untreated or stimulated with IL-1, and immunoprecipitated with anti-FLAG M2 antibody followed by Western immunoblotting using antibodies against IRAK and IRAK4. Interestingly, Pellino 1 indeed forms an IL-1-dependent signaling complex with the endogenous IRAK and IRAK4, strongly suggesting that it plays a role in IL-1-mediated signaling (Fig. 2a) .
Pellino 1 Is Required for IL-1-induced NFB Activation and IL-8 Gene Expression-We used small interfering RNA (siRNA), a new gene knock-down technology, to investigate the functional role of Pellino 1 in IL-1-mediated signaling pathways. Recently, a mammalian expression vector was developed that directs the synthesis of siRNA-like transcripts (pSUPER, suppression of endogenous RNA) (20) . Pellino 1-pSUPER has been generated and stably transfected into HEK293 cells. Northern analysis showed that 27% of the clones (clones 1, 3, 12, 16, and 18) transfected with Pellino 1-pSUPER had a 90% reduction of Pellino 1 mRNA (Fig. 3a) , whereas the clones transfected with vector showed the same levels of Pellino 1 mRNA (data not shown). As shown in Fig. 3b , IL-1 induced much weaker NFB activation in C-12 and C-16 (in which Pellino 1 expression is knocked down; Fig. 3a ) than in C-9 (a clone from the same transfection in which Pellino 1 expression is not altered, Fig. 3a) , strongly suggesting that Pellino 1 is required for IL-1-mediated NFB activation. The same expression levels of NFB were shown in these clones by immunoblotting with antibodies against p65 and p50 (Fig. 3b) . On the other hand, the reduced expression of Pellino 1 had no effect on tumor necrosis factor-induced NFB activation, indicating that Pellino 1 is specifically required for IL-1-dependent signaling. We also examined the effect of reduced Pellino 1 expression on IL-1-induced IL-8 gene expression, which was greatly reduced in C-12 and C-16 as compared with C-9 (Fig. 3c) , confirming that Pellino 1 is indeed required for this IL-1-mediated signaling pathway.
IL-1-induced Pellino 1-IRAK4-IRAK-TRAF6 Is an Intermediate Complex between IL-1 Receptor and TAK1 Complex-
Previous biochemical and genetic studies are consistent with a model for IL-1-mediated signaling (12) (Fig. 2c) . To address the molecular mechanism by which Pellino 1 functions in IL-1 signaling, we investigated whether Pellino 1 interacts with IRAK and IRAK4 in the receptor complex (Complex I) or the TAK1-containing Complex II. Cell extracts prepared from HEK293 cells transfected with FLAG-tagged Pellino 1, either untreated or stimulated with IL-1, were immunoprecipitated with anti-FLAG M2 (Fig. 2, a and b) , anti-TRAF6 (Fig. 2b) , and anti-TAK1 (data not shown) and anti-TAB2 (data not shown) antibodies followed by immunoblotting with antibodies against IRAK, TRAF6, IL-1 receptor, TAK1, and TAB2. As shown previously (12), TRAF6 is present both in the receptor complex (interacting with IL-1R and IRAK, Fig. 2, b and c) and the TAK1 complex (interacting with TAK1 and TAB2, Fig. 2, b and  c) . However, whereas Pellino 1 formed a complex with IRAK (Fig. 2, a and b), IRAK4 (Fig. 2a) , and TRAF6 (Fig. 2, a and b) , it co-immunoprecipitated with neither the IL-1 receptor (Fig.   FIG. 2. IL-1 (Fig. 2, a-c) .
Pellino 1 Functions Downstream of IRAK-Because most of the signaling components in the IL-1-mediated pathway are able to constitutively activate NFB upon overexpression, Pellino 1 was examined for this activity. Pellino 1 in a mammalian expression vector was co-transfected with NFB-dependent Eselectin-luc into HEK293 cells followed by luciferase reporter assay. Pellino 1 can activate the E-selectin promoter activity in a dose-dependent manner (Fig. 4a) . We have previously taken a genetic approach to studying IL-1-dependent signaling pathways through random mutagenesis, generating IL-1-unresponsive cell lines lacking specific components of the pathways. Mutant cell line I1A lacks both the IRAK protein and mRNA and is defective in IL-1-induced NFB and c-Jun NH 2 -terminal kinase activation (18, 18, 25) . As shown in Fig. 4a , whereas MyD88-mediated NFB activation is completely abolished in IRAK deficient I1A cells, Pellino 1-mediated NFB activation is intact in these cells, indicating that Pellino 1 functions downstream of IRAK. On the other hand, Pellino 1-induced NFB activation was inhibited by a dominant negative, kinase-inac- a, screening of clones with reduced expression of Pellino 1. Total RNA from HEK293 cells stably transfected with Pellino 1-pSUPER was analyzed by Northern procedure with a Pellino1 gene-specific probe. B, NFB gel-shift assay. Cell extracts from clones C-9, C-12, and C16, untreated or stimulated with IL-1 (2, 4, and 8 h) and tumor necrosis factor (2 h), were analyzed by NFB gel shift assay as described under "Experimental Procedures." The same extracts were analyzed by immunoblotting with anti-p65 and anti-p50. C, Northern analysis. RNA samples from C-9, C-12, and C16, untreated or stimulated with IL-1 (4, 8, 12, 24 h), were analyzed by using IL-8 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNAs as probes.
FIG. 4. Pellino 1 functions upstream of TAK1 and downstream
of IRAK. a, Pellino 1 leads to NFB activation in the IRAK-deficient I1A cells. FLAG-MyD88 (100 ng) and FLAG-Pellino 1 (100 ng) expression constructs were co-transfected with E-selectin-luc (100 ng) into HEK293 (WT, wild type) and the IRAK-deficient I1A cells, followed by luciferase reporter assay. The fold induction is relative to that in cells transfected with vector DNA (100 ng) and reporter DNA (100 ng). Shown are the averages and standard deviation from three independent experiments. b, kinase-dead TAK1 mutant (TAK1DN) inhibits Pellino 1-induced NFB activation. Increasing amounts of TAK1DN were cotransfected with FLAG-Pellino 1 (0.5 g) and E-selectin-luc (0.5 g) into HEK293 cells, followed by luciferase reporter assay. The fold induction is relative to that in cells transfected with only vector (3.5 g) and reporter DNA (0.5 g). Shown are the averages and standard deviation from three independent experiments. c, TAK1 leads to NFB activation in clones transfected with Pellino 1-pSUPER. TAK1 (0.5, 1, and 3 g of DNA) expression construct was co-transfected with E-selectin-luc (100 ng) into C9 (with normal Pellino 1 expression) and C12 (with reduced Pellino 1 expression), followed by luciferase reporter assay. The fold induction is relative to that in cells transfected with vector DNA (3 g) and reporter DNA (100 ng). Shown are the averages and standard deviation from three independent experiments. tive TAK1 mutant (TAK1 DN), indicating that Pellino1 must function upstream of TAK1 (Fig. 4b) . In support of this conclusion, TAK1 can still activate NFB in C-12, where Pellino 1 expression is greatly knocked down by RNA interference (Fig.  4c) . Taken together, the above results support the hypothesis that the Pellino 1-IRAK-IRAK4-TRAF6 signaling complex functions between the receptor complex (Complex I) and the TAK1 complex (Complex II).
DISCUSSION
One possible function for Pellino 1 is linking TRAF6 to IRAK in IL-1 signaling. However, several lines of evidence suggest that Pellino 1 is unlikely to be involved in the interaction between IRAK and TRAF6. First, several TRAF6 binding sites have been identified in both human and murine IRAK, and mutations in these sites abolish the ability of IRAK to activate NFB, suggesting that TRAF6 is likely to interact with IRAK directly through these sites (26) . Secondly, although our previous results have clearly shown that TRAF6 is recruited to the IL-1 receptor through its interaction with IRAK upon IL-1 stimulation (Fig. 2, b and c) (12) , Pellino 1 was not detected in the IL-1-induced receptor complex (IL-1R-IRAK-TRAF6, Complex I; Fig. 2, b and c) . Therefore, it is unlikely that Pellino 1 is responsible for the IL-1-induced interaction between IRAK and TRAF6.
Previous studies have shown that the release of phosphorylated IRAK from the receptor is essential for mediating downstream signaling events in response to IL-1 (27) . However, it is unclear how the phosphorylated IRAK is released from the receptor. The fact that Pellino 1 forms a complex with the phosphorylated IRAK but not with the IL-1 receptor upon IL-1 stimulation (Fig. 2, a and b) suggests that Pellino 1 may play an important role in facilitating the release of phosphorylated IRAK from the receptor.
It is important to note that Pellino 1 does interact with TRAF6 upon IL-1 stimulation, whereas it does not interact with TAK1, suggesting that Pellino 1 probably functions downstream of TRAF6 and upstream of TAK1. In support of this, a dominant negative mutant of TAK1 inhibits Pellino 1-mediated NFB activation (Fig. 4b) . The fact that Pellino 1 can activate NFB in IRAK-deficient cells (I1A) suggests that Pellino 1 may have a direct impact on the activation of TAK1. As a matter of fact, TAK1 is activated in I1A cells transfected with Pellino 1 (data not shown). It is quite possible that Pellino 1 has a transient interaction with the TAK1 complex, which could not be detected by the co-immunoprecipitation experiments (Fig. 2c) .
We have previously proposed a model for the IL-1 pathway (12). Taking the above findings of Pellino 1 into consideration, we now propose a modified model (Fig. 2c) . Upon IL-1 stimulation, adapter molecules MyD88 and Tollip are first recruited to the IL-1 receptor, which in turn recruits IRAK4, IRAK, and TRAF6, resulting in the formation of the receptor complex (Complex 1). During the formation of Complex I, IRAK4 is activated, leading to the hyperphosphorylation of IRAK, which creates an interface for the interaction of Pellino 1 with the IRAK4-IRAK-TRAF6 complex. The formation of Pellino 1-IRAK4-IRAK-TRAF6 causes conformational changes in the receptor complex (Complex I), which results in quick release of this intermediate complex (Pellino 1-IRAK4-IRAK-TRAF6 ) from the receptor. Through an unknown mechanism, the intermediate complex Pellino 1-IRAK4-IRAK-TRAF6 interacts with  the membrane-bound pre-associated TAK1-TAB1-TAB2, resulting in the formation of Complex II (TAK1 complex, IRAK-TRAF6-TAK1-TAB1-TAB2). TRAF6-TAK1-TAB1-TAB2 (Complex III) is then translocated from the membrane to the cytosol where TAK1 is activated, eventually resulting in the activation of NFB.
Although this study has shown the critical role of Pellino 1 in IL-1-mediated signaling, it was recently reported that a related protein, Pellino 2, modulates IL-1 and lipopolysaccharide (LPS) signaling (28) . At present, the relationship between Pellino 1 and Pellino 2 and their specific functions in IL-1 signaling are still unclear. One possibility is that each Pellino has its specific interaction with IRAK and/or IRAK4. The elucidation of precise functions of Pellino proteins in IL-1/TLR-mediated signaling will be an exciting and important research area in the future.
